← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Trellis Bioscience, Inc.
South San Francisco, CA
$29,790,683
Total funding
15
Grants
Funding over time
peak $4.5M · FY2011–24$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$29,790,683 · 15
By mechanism
R44$19,234,214 · 5
SB1$5,995,892 · 2
U44$2,593,872 · 2
R43$1,741,759 · 5
R41$224,946 · 1
Investigators at Trellis Bioscience, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Therapeutic antibody for RSV$1,499,589
R44 · FY2017 · AI
Therapeutic antibody for RSV$1,268,751
R44 · FY2016 · AI
Therapeutic Antibodies for CMV$1,000,000
R44 · FY2013 · AI
Therapeutic Antibody for RSV IIB$1,000,000
R44 · FY2020 · AI
Therapeutic Antibody for RSV IIB$1,000,000
R44 · FY2019 · AI
Therapeutic Antibodies for Biofilm Infections$999,961
SB1 · FY2019 · AI
Therapeutic Antibodies for Biofilm Infections$999,953
SB1 · FY2018 · AI
Therapeutic Antibodies for Biofilm Infections$999,953
SB1 · FY2017 · AI
Strain-Independent Therapeutic Antibodies for Influenza$999,820
R44 · FY2022 · AI
Therapeutic Antibodies for Biofilm Infections$999,628
R44 · FY2016 · AI
Strain-Independent Therapeutic Antibodies for Influenza$999,451
R44 · FY2021 · AI
Therapeutic Antibody for CMV$999,425
SB1 · FY2019 · AI
Strain-Independent Therapeutic Antibodies for Influenza$999,214
R44 · FY2020 · AI
Biofilm disrupting antibody to treat respiratory and musculoskeletal infections$999,192
R44 · FY2020 · AI
Therapeutic Antibody for CMV$999,000
SB1 · FY2017 · AI
HCMV Therapeutic Antibody Safety Trial$998,144
U44 · FY2023 · AI
HCMV Therapeutic Antibody Safety Trial$998,144
U44 · FY2024 · AI
Therapeutic Antibody for RSV IIB$997,704
R44 · FY2021 · AI
Therapeutic Antibody for CMV$997,600
SB1 · FY2018 · AI
Biofilm disrupting antibody to treat respiratory and musculoskeletal infections$990,949
R44 · FY2021 · AI